| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.002 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.096 | 0.002 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.099 | 0.003 |